Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Biol Psychiatry. 2023 Oct 1;94(7):591-600. doi: 10.1016/j.biopsych.2023.01.028. Epub 2023 Feb 9.
Our understanding of the impact of copy number variants (CNVs) on psychopathology and their joint influence with polygenic risk scores (PRSs) remains limited.
The UK Biobank recruited 502,534 individuals ages 37 to 73 years living in the United Kingdom between 2006 and 2010. After quality control, genotype data from 459,855 individuals were available for CNV calling. A total of 61 commonly studied recurrent neuropsychiatric CNVs were selected for analyses and examined individually and in aggregate (any CNV, deletion, or duplication). CNV risk scores were used to quantify intolerance of CNVs to haploinsufficiency. Major depressive disorder and generalized anxiety disorder PRSs were generated for White British individuals (N = 408,870). Mood/anxiety factor scores were generated using item-level questionnaire data (N = 501,289).
CNV carriers showed higher mood/anxiety scores than noncarriers, with the largest effects seen for intolerant deletions. A total of 11 individual deletions and 8 duplications were associated with higher mood/anxiety. Carriers of the 9p24.3 (DMRT1) duplication showed lower mood/anxiety. Associations remained significant for most CNVs when excluding individuals with psychiatric diagnoses. Nominally significant CNV × PRS interactions provided preliminary evidence that associations between select individual CNVs, but not CNVs in aggregate, and mood/anxiety may be modulated by PRSs.
CNVs associated with risk for psychiatric disorders showed small to large effects on dimensional mood/anxiety scores in a general population cohort, even when excluding individuals with psychiatric diagnoses. CNV × PRS interactions showed that associations between select CNVs and mood/anxiety may be modulated by PRSs.
我们对拷贝数变异 (CNV) 对精神病理学的影响及其与多基因风险评分 (PRS) 的联合影响的认识仍然有限。
英国生物库招募了 2006 年至 2010 年间居住在英国的 37 至 73 岁的 502534 人。经过质量控制,来自 459855 人的基因型数据可用于 CNV 调用。选择了 61 种常见的神经精神 CNV 进行分析,单独和总体(任何 CNV、缺失或重复)进行了分析。使用 CNV 风险评分来量化 CNV 对单倍体不足的不耐受性。为白种英国人(N=408870)生成了重度抑郁症和广泛性焦虑症 PRS。使用项目级问卷数据(N=501289)生成了情绪/焦虑因子得分。
CNV 携带者的情绪/焦虑得分高于非携带者,最明显的影响见于不耐受的缺失。共有 11 个个体缺失和 8 个重复与较高的情绪/焦虑相关。9p24.3(DMRT1)重复的携带者表现出较低的情绪/焦虑。当排除患有精神疾病的个体时,大多数 CNV 的关联仍然显著。名义上显著的 CNV-PRS 相互作用提供了初步证据,表明选择的个体 CNV 与情绪/焦虑之间的关联,但不是总体 CNV,可能由 PRS 调节。
与精神障碍风险相关的 CNV 对一般人群队列的多维情绪/焦虑评分有小到中等的影响,即使排除了患有精神疾病的个体。CNV-PRS 相互作用表明,选择的 CNV 与情绪/焦虑之间的关联可能受 PRS 调节。